SHARE: Change: 0.05 SEK / Bid: 9.95 SEK / Ask: 10.00 SEK / Price: 10.00 SEK / High: 10.00 SEK / Low: 9.60 SEK / Quantity: 5990 / Turnover: 59 577 SEK / 2017-09-18 22.00
1_6_red01

Spago Pix

Improved tumor visualization

1_7_red02

Tumorad

Tumor selective radiation treatment

1_8_red

Stock information

Share, calendar & reports

Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment

Optimizing cancer diagnostics and treatment

Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.

_1010729